High resolution nuclear magnetic resonance spectroscopy in clinical biology: Application in oncology

Anticancer Research

Volumn 16, Issue 3 B, 1996, Pages 1325-1331

  De Certaines, Jacques D ^a,b  

^a UNIVERSITÉ DE RENNES 1   (France)

^b Ctr Reg de Lutte Contre le Cancer   (France)

Author keywords

Clinical biology; Nuclear magnetic resonance spectroscopy; Oncology

Indexed keywords

TUMOR MARKER;

ANALYTIC METHOD; BODY FLUID; CONFERENCE PAPER; COST; HUMAN; HUMAN TISSUE; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE; TUMOR BIOPSY;

ANIMALS; HUMANS; MAGNETIC RESONANCE SPECTROSCOPY; NEOPLASMS;

EID: 0030017821     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (37)

1. Bell JD, Brown JCC, Sadler PJ: NMR spectroscopy of body fluids. Chemistry in Britain Oct: 1021-1024, 1988.
2. de Certaines JD (Ed): Magnetic resonance spectroscopy of biofluids: a new tool in clinical biology. World Sc Pub Co, London 1989.
3. Nicholson JK, Wilson ID: High resolution proton magnetic resonance spectroscopy of biological fluids. Progress in NMR Spectroscopy 21: 449-501, 1989.
4. de Certaines JD: High resolution magnetic resonance spectroscopy in clinical biology. Leukemia 4 (10): 667-670, 1990.
5. Bales JR, Higham DP, Howe L, Nichoson JK, Sadler PJ: Use of high resolution 1H NMR spectroscopy for rapid multi-component analysis of urine. Clin Chem 30: 426-432, 1984.
6. Eugène M, Le Moyec L, de Certaines JD, Desruennes M, Le Rumeur E, Fraysse JB, Cabrol C: Lipoproteins in Heart transplantation: proton MRS of plasma. Magn Reson in Med 18: 93-101, 1991.
7. Segalen J, de Certaines JD, Le Calvé M, Colleu D, Bansard JY, Rio M: 1H NMR of human seminal plasma in in-vivo fertilization attempts, interest of automatic spectrum analysis. J Reprod Fertil 103: 181-187, 1995.
8. Bell JD, Brown JCC, Sadler PJ, McLeod AF, Sonksen PH, Hughes RD, Williams R: High resolution proton NMR studies of human cerebrospinal. Fluid Clinical Science 72: 563-570, 1987.
9. Kriat M, Nicoli F, Vion-Dury J, Confort-Gouny S, Dano P, Grisoli F, Gastault JL, Cozzone P: La spectroscopie de RMN haute resolution du LCR: problemes methodologiques et perspectives d'applications cliniques. Ann Biol Clin 49: 461-467, 1991.
10. Mountford CE, Grossman G, Gatenby PA, Fox RM: High resolution proton NMR application to the study of leukaemic lymphocytes. Br J Cancer 41: 1000-1003, 1980.
11. Sibeldina LA, Yushmanov VE, Knubovets TL, Christianovitch DS, Shkarin PV, Semenova NA, High resolution 31P and 1H NMR spectroscopy in experimental oncology. Bruker Medical Report, 15-21, 1986.
12. Mountford CE, Holmes KT, Wright LC, May GL, Williams PG, Smith IPC: High resolution MRS detects metastatic potential, pp 111-118 In: Allen P, Boisvert DPJ, Lentle BC, (Eds), NMR in Cancer. Pergamon Press, New-York, 1986.
13. Aiken NR, Hsu EW, Blackband SJ: A review of NMR microimaging studies of single cells. J of Magn Res Analysis 1(I): 41-48, 1995.
14. Blumich B, Kuhn W (Ed): Magnetic Resonance Microscopy. Methods and Applications in Materials Science, Agriculture and Biomedicine. VCH Pub., New York 1992.
15. Odeblad E, Westin B: Proton Magnetic Resonance of human milk. Acta Radiol 49: 390-392, 1958.
16. Odeblad E:Department of medical research with NMR. Acta Isotopica 1: 27-33, 1961.
17. Ohsaka A, Yoshikawa K, Matuhasi T: Detection by 1H NMR of elevated lactate concentration in serum from patients with malignant tumours. Jap J Med Sci Biol 32: 305-309, 1979.
18. de Certaines JD, Bovée W and Podo F (Eds): Magnetic Resonance Spectroscopy in Biology and Medicine. Pergamon Press, London 1992.
19. Fossel ET, Carr JM, McDonagh J: Detection of Malignant tumors: water suppressed proton nuclear magnetic resonance spectroscopy of plasma. New Engl J of Med 315: 1369-1376, 1986.
20. Leray G, de Certaines JD: Proton NMR spectroscopy of plasma lipoproteins: a marker of the immune function in cancer disease? Anticancer Res 14: 1839-1852, 1994.
21. Otvos JD, Jeyarajah EJ, Hayes LW, Freedman DS, Janjan NA. Anderson T: Relationships between the Proton NMR properties of plasma lipoproteins and cancer. Clin Chem 37 (3): 369-376, 1991.
22. Hiltunen Y, Ala-Korpela M, Jokisaari J, Eskelinen S, Kivinhtty K: Proton NMR lineshape studies on human blood plasma lipids from newborn infants, healthy adults and adults with tumors. Magn Reson in Med 26: 89-99, 1992.
23. Kriat M, Vion-Dury J, Confort-Gouny S, Favre R, Viout P, Sciaky M, Sari H, Cozzone PJ: Analysis of plasma lipids by NMR spectroscopy: application to modifications induced by malignant tumors. J Lipid Research 34: 1009-1019, 1993.
24. Martino S, Malet-Martino MC: Fluorine-19 and phosphorus-31 MRS of human biofluids for drug metabolism studies, pp 83-102 In: de Certaines J.D. (Ed), Magnetic resonance spectroscopy of biofluids: a new tool in clinical biology. World Sc Pub Co, London 1989.
25. Bellemann ME, Brix G, Haberkorn U, Blatter J, Gerlach L, Oberdorfer F, Lorenz WJ: Fluorine-19 NMR Mapping of the Novel Anticancer Drug Gemcitabine in Experimental Tumor Systems. SMR Meeting, p 1685, Nice 1995.
26. Garrido L, Pfleiderer B, Tokareva E, Ackerman JL, Brady TJ: Detection of Silicon Compounds in Blood of Women with Breast Implants by 29Si NMR. SMR Meeting, p 154, Nice 1995.
27. Smith ICP, Princz EJ, Saunders JK: Magnetic Resonance Spectroscopy in Cancer Research. J Cancer Assoc Radiol 41: 32, 1990.
28. Mountford CE, Mackinnon WB, Delikatny EJ Russel P: High resolution Proton MRS in Cancer Pathology, pp 507-527. In: de Certaines, Bovee, Podo (Eds). MRs in Biology and Medicine, Pergamon Press, London 1992.
29. de Certaines JD, Larsen VA, Podo F, Carpinelli G, Briot O, Henriksen O: In vivo 31P MRS of experimental tumours: a review. NMR in Biomed 6: 345-365, 1993.
30. Mackinnon WB, Rckas A, Mountford CE: 1H MR spectral changes with cellular differentiation in human colorectal carcinoma cells. SMR Meeting, p 1703, Nice 1995.
31. Martinez-Perez I, Maxwell RJ, van den Boogaart A, Mazucco R, Griffiths JR Arus C: Pattern recognition analysis of 1H NMR spectra from human brain tumour biopsies. SMR Meeting, p 1709, Nice 1995.
32. Friesen L, Scarth G, Dolenko B, Nikulin A, Pizzi N, Somorjai R, Guijon F, Paraskevas M, Smith I: Dysplasia of the uterine cervix: classification via 1H MRS and multivariate analysis. SMR Meeting, p 1691, Nice 1995.
33. Mountford C, Wright L, Holmes KT, McKinnon WB, Gregory E, Fox RM: High resolution Proton NMR analysis of metastatic cancer cells. Science 226: 1415-1418, 1984.
34. Wright LC, May GL, Gregory P, Dyne M, Holmes KT, Williams PG Mountford CE: Inhibition of metastatic potential by fucosidase: an NMR study identifies a cell surface metastasis marker. J Cell Biochem 37: 49-59, 1988.
35. Wallace JC, Kitchen DG, Raaphorst GP, Somorjai RL, Ng CE, Fung MFK, Senterman M, Smith ICP: Classification of 1H MR spectra from untreated and recurrent ovarian cancer using linear discriminant analysis. SMR Meeting, p 1692, Nice 1995.
36. Black RD, Early TA, Roemer PB et al: High temperature super-conducting receiver for NMR microscopy. Science 259: 793-795, 1993.
37. Podo F, Bovée WMMJ, de Certaines JD, Henriksen O, Leach MO, Leibfritz D (Eds): Cancer and Brain Disease Characterization and Therapy Assessment by Quantitative MRS. Eurospin Annual Report, Rome 1994.